Gender and Race as Prognostic Factors In Patients Treated With Rituximab For B-Cell Non-Hodgkin Lymphoma

TY - JOUR

T1 - Gender and Race as Prognostic Factors In Patients Treated With Rituximab For B-Cell Non-Hodgkin Lymphoma

AU - Aparo, Santiago

AU - Gundabolu, K.

AU - Barta, S.

N1 - 624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II | Mendel Goldfinger, Santiago Aparo, Krishna Gundabolu, Stefan K Barta; Gender and Race As Prognostic Factors In Patients Treated With Rituximab For B-Cell Non-Hodgkin Lymphoma. 2013; 122 (21): 3053. doi: https://doi.org/10.1182/blood.V122.21.3053.3053 Download citation file:

PY - 2013

Y1 - 2013

UR - https://ashpublications.org/blood/article/122/21/3053/11277/Gender-and-Race-As-Prognostic-Factors-In-Patients

M3 - Article

VL - 122

JO - Blood

JF - Blood

ER -